Home > Name List By 2 > 2,6-Epoxy-2H-naphthaceno[1,2-b]oxocin-14-carboxylicacid, 11-[(6-deoxy-3-C-methyl-2,3,4-tri-O-methyl-a-L-mannopyranosyl)oxy]-4...

CAS No 1404-15-5 , 2,6-Epoxy-2H-naphthaceno[1,2-b]oxocin-14-carboxylicacid, 11-[(6-deoxy-3-C-methyl-2,3,4-tri-O-methyl-a-L-mannopyranosyl)oxy]-4-(dimethylamino)-3,4,5,6,9,11,12,13,14,16-decahydro-3,5,8,10,13-pentahydroxy-6,13-dimethyl-9,16-dioxo-,methyl ester, (2R,3S,4R,5R,6R,11S,13S,14R)-

  • Name: 2,6-Epoxy-2H-naphthaceno[1,2-b]oxocin-14-carboxylicacid, 11-[(6-deoxy-3-C-methyl-2,3,4-tri-O-methyl-a-L-mannopyranosyl)oxy]-4-(dimethylamino)-3,4,5,6,9,11,12,13,14,16-decahydro-3,5,8,10,13-pentahydroxy-6,13-dimethyl-9,16-dioxo-,methyl ester, (2R,3S,4R,5R,6R,11S,13S,14R)-
  • Synonyms: 2,6-Epoxy-2H-naphthaceno[1,2-b]oxocin-14-carboxylicacid, 11-[(6-deoxy-3-C-methyl-2,3,4-tri-O-methyl-a-L-mannopyranosyl)oxy]-4-(dimethylamino)-3,4,5,6,9,11,12,13,14,16-decahydro-3,5,8,10,13-pentahydroxy-6,13-dimethyl-9,16-dioxo-,methyl ester, (2R,3S,4R,5R,6R,11S,13S,14R)-;2,6-Epoxy-2H-naphthaceno[1,2-b]oxocin-14-carboxylicacid, 11-[(6-deoxy-3-C-methyl-2,3,4-tri-O-methyl-a-L-mannopyranosyl)oxy]-4-(dimethylamino)-3,4,5,6,9,11,12,13,14,16-decahydro-3,5,8,10,13-pentahydroxy-6,13-dimethyl-9,16-dioxo-,methyl ester, [2R-(2a,3b,4a,5b,6a,11b,13a,14a)]-; Nogalamycin (7CI,8CI);Antibiotic 205t3; U 15167; NSC 70845;
  • CAS Registry Number:
  • Melting Point: 787.803
  • Flash Point: 498.1°C
  • Boiling Point: 899.9°Cat760mmHg
  • Density: 1.49g/cm3
  • Refractive index: 1.648
  • Safety Statements: Poison by intravenous and intraperitoneal routes. Human mutation data reported. An antibiotic. When heated to decomposition it emits toxic fumes of NOx.
  • Hazard Symbols: T: Toxic;
  • Flash Point: 498.1°C
  • Molecular Weight: 787.8
  • InchiKey: KGTDRFCXGRULNK-BSVDYMIGSA-N
  • InChI: InChI=1S/C39H49NO16/c1-14-32(49-7)39(4,52-10)33(50-8)36(53-14)54-19-13-37(2,48)24(34(47)51-9)15-11-16-21(27(43)20(15)19)28(44)22-18(41)12-17-30(23(22)26(16)42)55-35-29(45)25(40(5)6)31(46)38(17,3)56-35/h11-12,14,19,24-25,29,31-33,35-36,41,43,45-46,48H,13H2,1-10H3/t14?,19-,24-,25-,29-,31+,32?,33?,35+,36?,37-,38+,39?/m0/s1
  • Risk Statements: 45-46-61-20/21/22
  • Molecular Formula: C39H49NO16
  • Molecular Structure:CAS No:1404-15-5 2,6-Epoxy-2H-naphthaceno[1,2-b]oxocin-14-carboxylicacid, 11-[(6-deoxy-3-C-methyl-2,3,4-tri-O-methyl-a-L-mannopyranosyl)oxy]-4-(dimethylamino)-3,4,5,6,9,11,12,13,14,16-decahydro-3,5,8,10,13-pentahydroxy-6,13-dimethyl-9,16-dioxo-,methyl ester, (2R,3S,4R,5R,6R,11S,13S,14R)-

Related products

Search by region :

Select to

1404-15-5 NOGALAMYCIN

  • Germany Cfm Oskar Tropitzsch [Manufacturer]
  • Tel: +49-9231-9619-0
  • Fax: +49-9231-9619-60
  • Address: Cfm Oskar Tropitzsch
    Waldershofer Str. 49-51
    95615 Marktredwitz
    Germany null,nullGermany
Contact Supplier

1404-15-5 NOGALAMYCIN

  • China Nanjing Chemlin Chemical Industry Co.,Ltd. [Manufacturer]
  • Tel: +86 25 8369-7070/ +86 138 51816776 (Mobile)
  • Fax: +86 25 8345-3275
  • Address: Rm.902 Longyin Plaza,
    No. 217 Zhongshan Rd.
    (N)Nanjing 210009,China null,nullChina
Contact Supplier

Select to

1/1
References of 2,6-Epoxy-2H-naphthaceno[1,2-b]oxocin-14-carboxylicacid, 11-[(6-deoxy-3-C-methyl-2,3,4-tri-O-methyl-a-L-mannopyranosyl)oxy]-4-(dimethylamino)-3,4,5,6,9,11,12,13,14,16-decahydro-3,5,8,10,13-pentahydroxy-6,13-dimethyl-9,16-dioxo-,methyl ester, (2R,3S,4R,5R,6R,11S,13S,14R)-
Title: Nogalamycin
CAS Registry Number: 1404-15-5
CAS Name: [2R-(2a,3b,4a,5b,6a,11b,13a,14a)]-11-[(6-Deoxy-3-C-methyl-2,3,4-tri-O-methyl-a-L-mannopyranosyl)oxy]-4-(dimethylamino)-3,4,5,6,9,11,12,13,14,16-decahydro-3,5,8,10,13-pentahydroxy-6,13-dimethyl-9,16-dioxo-2,6-epoxy-2H-naphthaceno[1,2-b]oxocin-14-carboxylic acid methyl ester
Manufacturers' Codes: U-15167; NSC-70845
Molecular Formula: C39H49NO16
Molecular Weight: 787.80
Percent Composition: C 59.46%, H 6.27%, N 1.78%, O 32.49%
Literature References: Antitumor antibiotic isolated from Streptomyces nogalater var. nogalater: B. K. Bhuyan, A. Dietz, Antimicrob. Agents Chemother. 1965, 836; B. K. Bhuyan et al., US 3183157 (1965 to Upjohn). Characterization: P. F. Wiley et al., Tetrahedron Lett. 1968, 663. Structure: eidem, J. Am. Chem. Soc. 99, 542 (1977). Stereochemistry: eidem, J. Org. Chem. 44, 4030 (1979). Biosynthesis: eidem, ibid. 43, 3457 (1978). Synthesis of L-nogalose, sugar component: L. Valente et al., Tetrahedron Lett. 1979, 1153; J. Yoshimura et al., Chem. Lett. 1979, 687. Partial stereospecific synthesis: R. P. Joyce et al., Tetrahedron Lett. 27, 4885 (1986). Molecular structure, absolute stereochemistry and interactions with DNA: S. K. Arora, J. Am. Chem. Soc. 105, 1328 (1983). Toxicity data: Z. Hadidian, PB Report 173334 (1966). Review of pharmacology: B. K. Bhuyan, C. G. Smith, Handb. Exp. Pharmacol. 38 (pt. 2), 623-632 (1975).
Properties: Orange-red solid from methanol, mp 195-196° (dec). [a]D25 +425° (c = 0.11 in CHCl3). pKa￠ 7.45 (60% ethanol). uv max (ethanol): 236, 258, 292 nm (e 52360, 24755, 9890). Sol in methylene chloride, acetone, chloroform, ethyl acetate. Insol in water, methanol, ethanol. LD50 in mice (mg/kg): 11.75 i.v., 4.79 i.p. (Hadidian).
Melting point: mp 195-196° (dec)
pKa: pKa￠ 7.45 (60% ethanol)
Optical Rotation: [a]D25 +425° (c = 0.11 in CHCl3)
Absorption maximum: uv max (ethanol): 236, 258, 292 nm (e 52360, 24755, 9890)
Toxicity data: LD50 in mice (mg/kg): 11.75 i.v., 4.79 i.p. (Hadidian)